Site icon Premium Alpha

Biogen Inc. (BIIB) Q3 2026 Earnings Name Transcript

Biogen Inc. (BIIB) Q3 2026 Earnings Name Transcript


Firm Individuals

Tim Energy – Head of Investor Relations
Christopher Viehbacher – President, CEO & Director
Priya Singhal – Govt VP & Head of Improvement
Robin Kramer – Govt VP & CFO
Alisha Alaimo – President & Head of North America

Convention Name Individuals

Philip Nadeau – TD Cowen, Analysis Division
Christopher Schott – JPMorgan Chase & Co, Analysis Division
Brian Abrahams – RBC Capital Markets, Analysis Division
Umer Raffat – Evercore ISI Institutional Equities, Analysis Division
Salveen Richter – Goldman Sachs Group, Inc., Analysis Division
Michael Yee – UBS Funding Financial institution, Analysis Division
Alexandria Hammond – Wolfe Analysis, LLC
Paul Matteis – Stifel, Nicolaus & Firm, Included, Analysis Division
Evan Seigerman – BMO Capital Markets Fairness Analysis
Geoffrey Meacham – Citigroup Inc., Analysis Division
David Amsellem – Piper Sandler & Co., Analysis Division
Danielle Brill Bongero – Truist Securities, Inc., Analysis Division
Mohit Bansal – Wells Fargo Securities, LLC, Analysis Division
Lin Tsai – Jefferies LLC, Analysis Division
Marc Goodman – Leerink Companions LLC, Analysis Division

Presentation

Operator

Good morning. My identify is Cynthia, and I shall be your convention operator right now. At the moment, I want to welcome everybody to the Biogen Third Quarter 2026 Earnings Name and Enterprise Replace. [Operator Instructions] At present’s convention is being recorded. Thanks.

I’d now like to show the convention over to Mr. Tim Energy, Head of Investor Relations. Mr. Energy, chances are you’ll start your convention.

Tim Energy
Head of Investor Relations

Thanks, Cynthia, and good morning, all people. Welcome to Biogen’s Third Quarter 2026 Earnings Name. Throughout this name, we are going to make forward-looking statements, which contain dangers and uncertainties that will trigger precise outcomes to vary materially from our forward-looking statements. We offer you a complete listing of danger components in our SEC filings, which I encourage you to assessment. Our earnings launch and different paperwork associated to our outcomes in addition to



Source link

Exit mobile version